Pharmaceutical Drug Development Process Explained by Medical Expert

Added:

Show Start
Medical Q&A
Fertility Issues
Trauma Bonding
Body Trends
Listener Calls
Post-Trauma
Drug Economics

Show Start

0:00
Playing Section
  • 1

    Host introduces show and studio guests.

  • 2

    Discusses personal medical stories like teratoma surgery.

  • 3

    Begins answering listener emails on health topics.

Basic concepts of pharmacology, including pharmacokinetics (how the body processes drugs) and pharmacodynamics (how drugs affect the body).
An overview of the clinical trial process, specifically the distinct objectives of Phase I, II, and III human trials.
Fundamental human anatomy and physiology, particularly how the nervous and endocrine systems regulate systemic bodily functions.
The role of regulatory bodies, such as the FDA, in establishing guidelines for drug safety, efficacy, and labeling.
Advanced principles of Pharmacovigilance, focusing on post-marketing surveillance (Phase IV) and signal detection for adverse drug reactions.
The concept of drug repurposing (repositioning), where side effects discovered during trials lead to new therapeutic indications.
Pharmacogenomics, exploring how genetic variations among individuals influence drug metabolism and the occurrence of side effects.
Bioethics in clinical research, including patient safety, informed consent, and the ethics of reporting adverse trial outcomes.
72.2K views1.8Klikes1:03:50@YMHStudiosOriginal Release: 2023-09-29

Pharmaceutical research follows a strict timeline where companies have only 10 years from identifying a molecule to bring it to market and profit, with an average of 5 years and over $1 billion required to develop a new drug. This economic pressure drives pharmaceutical companies to create 'me-too' drugs (slight modifications of existing drugs) to maximize profits during the patent period, as they only have 5 years to recoup their investment before the drug becomes generic and loses patent protection.